BSE filing, NSE: OMKARPH. Summary written from the filing by ALFA Finder's alert engine.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹6.25
- Market cap
- ₹6.30 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 74.0×Sector 34.1×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Other Announcement
Omkar Pharmachem Ltd filed its quarterly shareholding pattern and provided an explanation regarding missing PAN details for certain public shareholders.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Limited concluded its 31st Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and approval of material related party transactions.
Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Board Meeting Outcome
Omkar Pharmachem Ltd has announced the outcome of its board meeting, including the schedule for its 31st Annual General Meeting and related party transactions approval.
Omkar Pharmachem Q1 FY27 Results: Net Profit ₹0 Cr
Omkar Pharmachem Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other board meeting date announcements
All →Banas Finance Board Meeting Date
Banas Finance schedules a board meeting on 5 November 2026 to approve unaudited Q2 and half-year results. Trading window stays closed until 48 hours after results declaration.
Thirumalai Chemicals Board Meeting Date
Thirumalai Chemicals has informed the exchanges that its board will meet on November 5, 2026. The meeting will consider unaudited results for the quarter and half year ended September 30, 2026.
Super Spinning Mills Board Meeting Date
Super Spinning Mills schedules its board meeting for November 5, 2026 to consider unaudited quarterly results. Trading window stays closed until 48 hours after the meeting.
Lead Reclaim and Rubber Products Board Meeting Date
Lead Reclaim will meet on 05 November 2026 to consider half-yearly unaudited results for September 2026. Trading window remains closed until 07 November 2026.
Oval Projects Engineering Board Meeting Date
Oval Projects Engineering will hold a board meeting on November 4, 2026 to consider half-year results and a warrant issue. Agenda items are proposed; no amount stated.
Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.